You just read:

Polaryx Therapeutics Receives IND Approval for PLX-200 From the FDA for the Treatment of Late Infantile Neuronal Ceroid Lipofuscinosis

News provided by

Polaryx Therapeutics, Inc

Jan 20, 2020, 11:00 ET